+1,982.4%
AXTI vs GSK
+31.2%
+1,951.2%
-73.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.7% | -1.9% | +11.6% | +9.0% |
| 7D | +5.1% | -1.8% | +7.0% | +4.6% |
| 30D | -10.2% | -2.2% | -8.0% | -10.4% |
| 3M | -41.8% | -1.8% | -40.0% | -41.8% |
| 6M | +57.5% | -10.6% | +68.1% | +59.5% |
| YTD | +277.0% | +4.4% | +272.6% | +286.3% |
| 1Y | +1,982.4% | +30.4% | +1,952.0% | +2,018.5% |
| All | +1,982.4% | +31.2% | +1,951.2% | +2,018.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling